Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Cash from Financing Activities (2016 - 2025)

HealthLynked (HLYK) has disclosed Cash from Financing Activities for 10 consecutive years, with $435001.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Financing Activities fell 50.52% to $435001.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.6 million, a 40.91% decrease, with the full-year FY2024 number at $2.9 million, up 251.99% from a year prior.
  • Cash from Financing Activities was $435001.0 for Q3 2025 at HealthLynked, up from $415467.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $4.4 million in Q1 2021 to a low of -$7700.0 in Q4 2021.
  • A 5-year average of $815475.0 and a median of $435001.0 in 2025 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: crashed 109.01% in 2021, then surged 6646.84% in 2022.
  • HealthLynked's Cash from Financing Activities stood at -$7700.0 in 2021, then soared by 6646.84% to $504107.0 in 2022, then plummeted by 59.94% to $201957.0 in 2023, then soared by 88.1% to $379885.0 in 2024, then increased by 14.51% to $435001.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Cash from Financing Activities are $435001.0 (Q3 2025), $415467.0 (Q2 2025), and $378582.0 (Q1 2025).